HUTCHMED (China) Ltd: Form 20-F for the period ended Dec 31, 2025
Filed with the SEC on Mar 5, 2026 and accepted by EDGAR at Mar 5, 2026, 07:27 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2025-01-01 to 2025-12-31 | $548.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2025-01-01 to 2025-12-31 | $336.3m | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 12 months2025-01-01 to 2025-12-31 | $148.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2025-01-01 to 2025-12-31 | −$39.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2025-01-01 to 2025-12-31 | $2.9m | us-gaap:InterestExpenseNonoperating |
| Income tax | 12 months2025-01-01 to 2025-12-31 | $63.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2025-01-01 to 2025-12-31 | $456.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2025-01-01 to 2025-12-31 | $0.52 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2025-01-01 to 2025-12-31 | $0.53 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2025-01-01 to 2025-12-31 | 872,891,120 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2025-01-01 to 2025-12-31 | −$64.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2025-01-01 to 2025-12-31 | $14.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2025-12-31 | $71.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-12-31 | $1.57bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $1.75bn | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $315.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $501.8m | us-gaap:Liabilities |
| Long-term debt | At period end2025-12-31 | $68.2m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2025-12-31 | $25.0m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2025-12-31 | $25.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2025-12-31 | $1.24bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2025-12-31 | 872,327,620 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001104659-26-023822. Last ingested by Listed: Nov 5, 2026, 11:21 ET. Listed shows no prices and gives no investment advice.